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Guest Editorial 
Dietarv Antioxidants and Dementia 
J 
As the populations of the developed 
world continue to age, the number of 
people who develop Alzheimer’s dis- 
ease (AD) or other forms of dementia is 
set to rise. In the United States, for exam- 
ple, the prevalence of AD is projected to 
quadruple over the next 50 years (Brook- 
meyer & Gray, 2000). The search for fac- 
tors that might help to prevent or treat 
these conditions has therefore assumed 
a particular relevance. 
One hypothesis that has attracted con- 
siderable interest in recent years sug- 
gests that oxidative stress plays an 
important part in the pathogenesis of 
AD, vascular dementia (VaD), and other 
age-related degenerative conditions 
(Beckman & Ames, 1998; Christen, 2000). 
Around 2%-3% of the oxygen consumed 
by cells ends up as highly destructive 
oxygen free radicals that can damage the 
cell nucleus, mitochondria1 DNA, mem- 
branes, and cytoplasmic proteins, and 
are thought to play a crucial role in 
atherogenesis (Witztum, 1994). The rate 
at which this damage accumulates de- 
pends on the balance between the gener- 
ation of toxic free radicals such as 
superoxide and hydrogen peroxide and 
the adequacy of the body’s antioxidant 
defenses. The brain is particularly sus- 
ceptible to damage by free radicals be- 
cause its metabolism requires large 
quantities of oxygen and its membranes 
are rich in polyunsaturated fatty acids, 
which are prone to lipid peroxidation 
(Markesbery &Carney, 1999). Recent re- 
search investigating oxidative stress in 
patients with AD found that levels of 
two markers of lipid peroxidation (4- 
hydroxynonenal and the isoprostane, 
8,12,-iso-iPF2alpha-V1) were higher than 
those seen in controls and that the extent 
of lipid peroxidation in these patients 
correlated with measures of cognitive or 
functional impairment (McGr a th e t al., 
2001; Pratico et al., 2000). Such findings 
raise the possibility that increasing the 
body’s antioxidant defenses by dietary 
means might improve the symptoms of 
dementia or prevent it from developing. 
An article in this issue of the journal (see 
pp. 265-275) sets out to explore the rela- 
tion between dietary intake and antioxi- 
dant status in people with dementia. Naji 
Tabet and colleagues studied 51 patients 
with AD, VaD, or dementia with Lewy 
bodies (DLB) and 30 controls and com- 
pared their dietary intake of vitamin D, 
vitamins B,, B,, and BI2, folate, niacin, ribo- 
flavin, biotin, pantothenate, copper, zinc, 
and selenium with blood levels of the en- 
dogenous antioxidants glutathione per- 
oxidase and superoxide dismutase, and 
total antioxidant capacity (TAC). They 
found that patients with severe AD had a 
lower intake of most of the vitamins and 
trace elements than the control group, but 
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there were no differences in antioxidant 
status between any of the dementia groups 
and the controls. The men and women 
making up the control group in this study 
were younger, on average, than those in 
the dementia groups. Whether adjusting 
for age would have made any difference to 
these results is not clear. In some studies 
where an age-matched control group has 
been used, there have been no differences 
in vitamin or mineral intake between de- 
mented and nondemented subjects (Burns 
et al., 1989) nor has there been any differ- 
ence in TAC (Foy et al., 1999), though a 
study that measured total radical-trapping 
antioxidant capacity did find that this was 
significantly reduced in demented patients 
compared with the age-matched controls 
(De Leo et al., 1998). Among the subjects 
studied by Tabet and colleagues, there 
was no evidence that TAC was linked to 
dietary intake of the vitamins and miner- 
als measured in those with AD or DLB, but 
there were significant positive associations 
between TAC and intake of vitamin B,, 
vitamin BI2, zinc, and selenium in subjects 
with VaD. 
Most of the studies that have examined 
whether there is a link between antioxi- 
dant status and disorders in cognitive 
function have concentrated on intake or 
blood concentrations of the major antiox- 
idant vitamins, vitamin C, vitamin E, and 
beta-carotene. The evidence from these 
observational studies provides some sup- 
port for the idea that higher antioxidant 
intakes might be protective, though it is 
not consistent. In the Rotterdam study of 
over 5,000 nondemented elderly people, 
for example, higher carotene intake was 
associated, in a cross-sectional analysis, 
with better performance on the Mini- 
Mental State Examination, but no rela- 
tion was found with intake of vitamins C 
and E (Jama et al., 1996). A recent report 
on a subset of this same cohort showed 
that people with high blood concentra- 
tions of carotenoids had fewer white- 
matter lesions on magnetic resonance 
imaging (den Heijer et al., 2001). In 4,800 
elderly participants in the NHANES I11 
survey, higher blood concentrations of 
vitamin E were associated with better 
memory performance, but no significant 
relations were found with concentrations 
of vitamin C and beta-carotene (Perkins 
et al., 1999). In the Zutphen Elderly Study, 
no associations were found between in- 
take of any antioxidant and cognitive 
function (Kalmijn et al., 1997). All these 
studies controlled for potential confound- 
ing factors such as age, education, and 
vascular risk factors, but the fact that they 
were cross-sectional makes it impossible 
to be certain about the direction of any 
relation found between low intake or 
blood concentrations of antioxidant vita- 
mins and impaired cognition. Similar dif- 
ficulties arise when interpreting the 
results of studies showing that demented 
patients have lower blood concentrations 
of antioxidant vitamins than nondement- 
ed controls (Foy et al., 1999; Zaman et al., 
1992). Such associations could result from 
the influence of the disease process itself 
on dietary habits or antioxidant status, 
rather than reflecting any protective ef- 
fect of these vitamins. However, recent 
reports of studies where data on antioxi- 
dant status were collected prior to the 
development of cognitive impairment 
provide rather stronger evidence. After 6 
years of follow-up of the Rotterdam study 
cohort, people who at baseline had a high- 
er intake of vitamin E or vitamin C or 
whose diet was richer in vegetables had a 
significantly reduced incidence of AD or 
all forms of dementia (Engelhart et al., 
2000). Suggestions that vitamin E or C 
might be protective have also come from 
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the longitudinal Honolulu-Asia Aging 
Study. Here, men who had reported tak- 
ing both vitamin E and vitamin C supple- 
ments were significantly less likely to 
develop VaD during the follow-up peri- 
od (odds ratio 0.12,95% confidence inter- 
val 0.02-0.88), though risk of AD was not 
reduced (Masaki et al., 2000). Whether 
the reduction in risk seen in the men 
taking supplements was due to the vita- 
mins themselves or merely a reflection of 
the distinctive characteristics of supple- 
ment users is not clear (Lyle et al., 1998). 
As yet there are no data from random- 
ized controlled trials on the effect of 
antioxidant vitamins in preventing de- 
mentia. There is some evidence from a 
trial of vitamin E and selegiline in pa- 
tients with AD that vitamin E may delay 
the progression of the disease, as mea- 
sured by time to institutionalization, loss 
of ability to perform basic activities of 
daily life, or death, but it did not affect 
cognitive function (Sano et al., 1997). 
Until more data are available from ran- 
domized controlled trials, the uncertain- 
ties about the usefulness of antioxidant 
vitamins in the prevention or treatment 
of dementia are unlikely to be resolved. 
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